This will be of interest to brain-heads and neuro-geeks.
David Nichols, Professor of Medicinal Chemistry and Pharmacology at Purdue University and founder of the Heffter Research Institute, presents his research at the first Basel LSD Symposium.
I wonder how the recent research showing that endogenous DMT is more of a sigma-1 recepter agonist than a 5-HT2a transmitter might affect these theories.
Advertisement
Recent Comments